SCHEMBL2310288

SCHEMBL2310288

OCCc1ccc2c3ccccc3c3ccccc3c2c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.52
ALDH1A1 P00352 2/20 0.50
BACE1 P56817 2/20 0.50
KDM4E B2RXH2 1/20 0.50
ALOX5 P09917 1/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 1/20 0.50
CA2 P00918 2/20 0.44
BAD Q92934 2/20 0.44
CYP4F2 P78329 2/20 0.43
CYP4A11 Q02928 2/20 0.43
PDK2 Q15119 1/20 0.41
CYP1A2 P05177 3/20 0.40
CYP2D6 P10635 3/20 0.40
CYP2C19 P33261 3/20 0.40
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
HIF1A Q16665 1/20 0.38
TSHR P16473 2/20 0.36
CA12 O43570 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2312897 0.86 CYP1A2 (0.57) TDP1ALDH1A1BACE1KDM4EALOX5
SCHEMBL2311816 0.85 IGF1R (0.44) TDP1CA2CYP4F2CYP4A11CYP1A2
SCHEMBL2314155 0.84 CYP1A2 (0.44) TDP1ALDH1A1BACE1KDM4EALOX5
SCHEMBL8376185 0.84 TDP1 (0.45) TDP1ALDH1A1BACE1KDM4EALOX5
SCHEMBL2309813 0.83 CYP1A2 (0.47) TDP1ALDH1A1BACE1KDM4EALOX5
SCHEMBL2307222 0.83 CYP1A2 (0.47) TDP1ALDH1A1BACE1KDM4EALOX5
SCHEMBL2310522 0.82 HPRT1 (0.52) TDP1ALDH1A1BACE1KDM4EALOX5
SCHEMBL2310005 0.82 KDM4E (0.50) TDP1ALDH1A1BACE1KDM4EALOX5
SCHEMBL2313600 0.82 CYP1A2 (0.42) TDP1ALDH1A1BACE1KDM4EALOX5
SCHEMBL2308691 0.82 CYP1A2 (0.42) TDP1ALDH1A1BACE1KDM4EALOX5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7989517-B2 Actinic ray curable composition, actinic ray curable ink, and image formation process employing the same KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2011-08-02 US disclosed
US-20070123600-A1 ACTINIC RAY CURABLE COMPOSITION, ACTINIC RAY CURABLE INK, AND IMAGE FORMATION PROCESS EMPLOYING THE SAME KONICA MINOLTA MEDICAL & GRAPHIC, INC. (JP) 2007-05-31 US disclosed